Tag: proceedings

Molecular signature for outcomes of triple negative breast cancer

| April 13, 2015 | 0 Comments

( University of Utah Health Sciences ) Compared to other types of breast cancer, triple negative breast cancers are often more aggressive and have fewer treatment options. In a new study published in the journal Proceedings of the National Academy of Sciences, researchers at Huntsman Cancer Institute and the University of Utah have identified a molecular mechanism that triple negative breast …

Continue Reading

A way to kill chemo-resistant ovarian cancer cells: Cut down its protector

| September 24, 2014 | 0 Comments

( Ottawa Hospital Research Institute ) Ovarian cancer is the most deadly gynecological cancer, claiming the lives of more than 50 percent of women who are diagnosed with the disease. A study involving Ottawa and Taiwan researchers, published today in the influential Proceedings of the National Academy of Sciences (PNAS), provides new insight into why ovarian cancer is often resistant to …

Continue Reading

U.S. judge strikes sealing order over Garlock asbestos liability

| July 24, 2014 | 0 Comments

A North Carolina federal judge has struck down a bankruptcy court ruling that sealed evidence and testimony about gasket maker Garlock Sealing Technologies' liability for asbestos injuries, saying no compelling reason was stated to close the proceedings. The “public and press have a co-extensive right to view and consider documents tendered” in court, wrote U.S. District Judge Max Cogburn in the …

Continue Reading

Two new possible drug targets for triple negative breast cancer

| May 27, 2014 | 0 Comments

( Houston Methodist ) The suppression of two genes reduce breast cancer tumor formation and metastasis by interfering with blood vessel formation and recruitment, report scientists in the Proceedings of the National Academy of Sciences. The findings may help medical researchers identify effective drug targets for triple negative breast cancer, or TNBC.

Continue Reading

'Dustman' protein helps bin cancer cells

| April 21, 2014 | 0 Comments

( Cancer Research UK ) Cancer researchers have discovered a new 'dustman' role for a molecule that helps a drug kill cancer cells according to a study, published in the journal Proceedings of the National Academy of Sciences.

Continue Reading

'Dustman' protein helps bin cancer cells

| April 21, 2014 | 0 Comments

( Cancer Research UK ) Cancer researchers have discovered a new ‘dustman’ role for a molecule that helps a drug kill cancer cells according to a study, published in the journal Proceedings of the National Academy of Sciences.

Continue Reading

Study Questions Anti-Cancer Mechanisms of Drug Tested in Clinical Trials

| January 13, 2014 | 0 Comments

CINCINNATI, Jan. 13, 2014 /PRNewswire-USNewswire/ — The diabetes drug metformin is also being tested in numerous clinical trials for treating different cancers, and several studies point to its apparent activation of a molecular regulator of cell metabolism called AMPK to suppress tumor growth. But new research appearing the week of Jan

Continue Reading

Depletion of 'Traitor' Immune Cells Slows Cancer Growth in Mice

| September 16, 2013 | 0 Comments

Scientists at the University of Washington have developed a strategy to slow tumor growth and prolong survival in mice with cancer by targeting and destroying a type of cell that dampens the body's immune response to cancer.

Continue Reading

University of Maryland researchers identify fish protein that may inhibit cancer metastasis

| March 19, 2013 | 0 Comments

Researchers at the University of Maryland School of Medicine have identified a peptide, or protein, derived from Pacific cod that may inhibit prostate cancer and possibly other cancers from spreading, according to preclinical research published online in the Proceedings of the National Academy of Sciences.

Continue Reading